TRIM21 and breast cancer: The subjects with overlapping anti-Ku antibodies and malignancy had melanoma (ARNAP overlap), breast cancer (ACA overlap), and squamous cell skin cancer (ACA and anti-Ro52/TRIM21 overlap), respectively, none of which occurred within 2 years of SSc diagnosis.